IL-35-mediated induction of a potent regulatory T cell population

Nature Immunology

Volumn 11, Issue 12, 2010, Pages 1093-1101

  Collison, Lauren W ^a   Chaturvedi, Vandana ^a   Henderson, Abigail L ^a,f   Giacomin, Paul R ^b   Guy, Cliff ^a   Bankoti, Jaishree ^a   Finkelstein, David ^a   Forbes, Karen ^a   Workman, Creg J ^a   Brown, Scott A ^a   Rehg, Jerold E ^a   Jones, Michael L ^c   Ni, Hsiao Tzu ^d   Artis, David ^b   Turk, Mary Jo ^e   Vignali, Dario A A ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Shenandoah Biotechnology   (United States)

^d R and D Systems Inc   (United States)

^e DARTMOUTH MEDICAL SCHOOL   (United States)

^f DES MOINES UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 35; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADENOCARCINOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENTERITIS; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IN VIVO STUDY; MELANOMA B16; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TRICHURIASIS; TRICHURIS; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

ANIMALS; CELL DIFFERENTIATION; CELL SEPARATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNE TOLERANCE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INTERLEUKINS; LYMPHOCYTE ACTIVATION; MICE; MICROSCOPY, CONFOCAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 78449296907     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1952     Document Type: Article

References (50)

1. Fontenot, J.D., Rasmussen, J.P., Gavin, M.A. & Rudensky, A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6, 1142-1151 (2005)
2. Gavin, M.A. et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445, 771-775 (2007)
3. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003)
4. Waldmann, H., Adams, E., Fairchild, P. & Cobbold, S. Infectious tolerance and the long-term acceptance of transplanted tissue. Immunol. Rev. 212, 301-313 (2006)
5. + regulatory T lymphocytes through the induction of anergy and infectious tolerance. J. Immunol. 180, 2830-2838 (2008)
6. lo/- natural regulatory T cells in human allergic asthma. Am. J. Respir. Crit. Care Med. 180, 823-833 (2009)
7. Bluestone, J.A. & Abbas, A.K. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3, 253-257 (2003)
8. Shevach, E.M. From vanilla to 28 favors: multiple varieties of T regulatory cells. Immunity 25, 195-201 (2006)
9. Workman, C.J., Szymczak-Workman, A.L., Collison, L.W., Pillai, M.R. & Vignali, D.A. The development and function of regulatory T cells. Cell. Mol. Life. Sci. 6, 2603-2622 (2009)
10. Roncarolo, M.G. et al. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212, 28-50 (2006)
11. Verbsky, J.W. Therapeutic use of T regulatory cells. Curr. Opin. Rheumatol. 19, 252-258 (2007)
12. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886 (2003)
13. + T-cell subset inhibits antigen-specifc T-cell responses and prevents colitis. Nature 389, 737-742 (1997)
14. Collison, L.W. et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450, 566-569 (2007)
15. Sakaguchi, S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101, 455-458 (2000)
16. + regulatory T cells rescue scurfy mice. Eur. J. Immunol. 38, 1814-1821 (2008)
17. reg suppression assays. in Regulatory T cells: Methods and Protocols (Springer-Humana, New York, in the press
18. Annacker, O., Pimenta-Araujo, R., Burlen-Defranoux, O. & Bandeira, A. On the ontogeny and physiology of regulatory T cells. Immunol. Rev. 182, 5-17 (2001)
19. Workman, C.J. et al. Lymphocyte activation gene-3 (CD223) regulates the size of the expanding T cell population following antigen activation in vivo. J. Immunol. 172, 5450-5455 (2004)
20. + regulatory T cells suppress antigen-specifc autoreactive immune responses and central nervous system infammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169, 4712-4716 (2002)
21. + regulatory cells within the central nervous system. J. Immunol. 175, 3025-3032 (2005)
22. Turk, M.J. et al. Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. J. Exp. Med. 200, 771-782 (2004)
23. Zhang, P., Cote, A.L., de Vries, V.C., Usherwood, E.J. & Turk, M.J. Induction of postsurgical tumor immunity and T-cell memory by a poorly immunogenic tumor. Cancer Res. 67, 6468-6476 (2007)
24. Izcue, A., Coombes, J.L. & Powrie, F. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal infammation. Immunol. Rev. 212, 256-271 (2006)
25. + T helper cells. J. Exp. Med. 196, 255-260 (2002)
26. Milojevic, D., Nguyen, K.D., Wara, D. & Mellins, E.D. Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development. Pediatr Rheumatol Online J 6, 20 (2008)
27. Waldmann, H. Tolerance can be infectious. Nat. Immunol. 9, 1001-1003 (2008)
28. Collison, L.W., Pillai, M.R., Chaturvedi, V. & Vignali, D.A. Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner. J. Immunol. 182, 6121-6128 (2009)
29. D'Elia, R., Behnke, J.M., Bradley, J.E. & Else, K.J. Regulatory T cells: a role in the control of helminth-driven intestinal pathology and worm survival. J. Immunol. 182, 2340-2348 (2009)
30. Di Stasi, A. et al. T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model. Blood 113, 6392-6402 (2009)
31. Liyanage, U.K. et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J. Immunol. 169, 2756-2761 (2002)
32. + effector T cells. J. Exp. Med. 159, 1295-1311 (1984)
33. Olkhanud, P.B. et al. Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells. Cancer Res. 69, 5996-6004 (2009)
34. Zou, W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat. Rev. Cancer 5, 263-274 (2005)
35. Zou, W. Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 6, 295-307 (2006)
36. Kocak, E. et al. Combination therapy with anti-CTL antigen-4 and anti-4-1BB antibodies enhances cancer immunity and reduces autoimmunity. Cancer Res. 66, 7276-7284 (2006)
37. Peggs, K.S., Quezada, S.A., Chambers, C.A., Korman, A.J. & Allison, J.P. Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies. J. Exp. Med. 206, 1717-1725 (2009)
38. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195, 603-616 (2002)
39. + cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421, 388-392 (2003)
40. + regulatory T cells confer infectious tolerance in a TGF-β-dependent manner. J. Exp. Med. 205, 1975-1981 (2008)
41. Allan, S.E., Song-Zhao, G.X., Abraham, T., McMurchy, A.N. & Levings, M.K. Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3. Eur. J. Immunol. 38, 3282-3289 (2008)
42. + regulatory T cells do not constitutively express IL-35. J. Immunol. 181, 6898-6905 (2008)
43. Horwitz, D.A. et al. Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease. Semin. Immunol. 16, 135-143 (2004)
44. Schwartz, R.H. Models of T cell anergy: is there a common molecular mechanism? J. Exp. Med. 184, 1-8 (1996)
45. Vignali, D.A. & Vignali, K.M. Profound enhancement of T cell activation mediated by the interaction between the TCR and the D3 domain of CD4. J. Immunol. 162, 1431-1439 (1999)
46. Huang, C.T. et al. Role of LAG-3 in regulatory T cells. Immunity 21, 503-513 (2004)
47. Rocke, D.M. & Durbin, B. Approximate variance-stabilizing transformations for gene-expression microarray data. Bioinformatics 19, 966-972 (2003)
48. Koch, M.A. et al. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 infammation. Nat. Immunol. 10, 595-602 (2009)
49. + regulatory T cells. J. Immunol. 170, 3939-3943 (2003)
50. Artis, D. et al. The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity. J. Immunol. 173, 5626-5634 (2004